Endothelin-1 is not only a powerful vasoconstrictor but also a potent mitogen for vascular smooth muscle cells (SMC), acting through both the endothelin-A and endothelin-B receptor (ET B -R). Although vascular SMC are known to express the ET B -R, its transcriptional regulation has not been studied thus far. Here we demonstrate that the potent inhibitor of nuclear factor B activation, pyrrolidine dithiocarbamate (PDTC; 30 -100 M), induces de novo ET B -R expression in rat aortic and mesenteric cultured SMC. Electrophoretic mobility shift analyses revealed that besides inhibition of nuclear factor B, PDTC enhances activator protein-1 (AP-1), CCAAT/enhancer-binding protein (C/EBP), and GATA-2 activity in these cells. Preincubation of PDTC-stimulated cells with appropriate decoy oligodeoxynucleotides confirmed the involvement of these three transcription factors, namely that of AP-1, in ET B -R expression. The stimulatory effect of PDTC on ET B -R expression was also confirmed functionally by monitoring an enhanced ET-1-induced apoptosis in PDTC-treated cells that was sensitive to the ET B -R antagonist, BQ788. Taken together, these findings demonstrate that C/EBP, GATA-2, and in particular AP-1 can control ET B -R expression in vascular SMC. They further support the notion that ET B -R expression in these cells may play an important role in cardiovascular complications, such as restenosis following angioplasty that in the early phase is characterized by prominent SMC apoptosis.
The endothelins constitute a family of three closely related peptides (ET-1, ET-2, and ET-3) with diverse physiological and pathophysiological actions ranging from embryogenesis to heart failure. In the cardiovascular system, ET-1 is the main representative of these 21 amino acid peptides. Predominantly formed by endothelial cells lining the luminal surface of the blood vessels, ET-1 is not only a powerful vasoconstrictor, but also a potent mitogen for vascular smooth muscle cells (SMC). It is derived from a 212 amino acid precursor, preproendothelin-1, that is sequentially processed to big ET-1 and ET-1 by a furin-like protease and one or several endothelin-converting enzymes (Parris and Webb, 1997; Schiffrin et al., 1997) . ET-1 exerts its biological effects mainly through activation of two types of seven transmembrane-spanning G protein-coupled receptors, designated ET A -R and ET B -R. Although SMC express both types of receptors, ET A -R activation appears to predominantly modulate SMC tone and proliferation in arteries, whereas in veins ET-1 seems to exert these effects primarily through activation of the ET B -R (Douglas and Ohlstein, 1997) . Endothelial cells also express an ET B -R, the activation of which promotes the release of nitric oxide and prostacyclin, thereby potentially limiting an excessive ET A -R and/or ET B -R-mediated, ET-1-induced vasoconstriction.
The development of specific endothelin receptor antagonists has provided some important insights into the pathophysiological significance of the endothelin system in cardiovascular disease (Kirchengast and Munter, 1999) . Thus, ET-1 may contribute to the intimal hyperplasia of venous bypass grafts through activation of the ET A -R (Dashwood et al., 1998) and/or ET B -R (Porter et al., 1998) . Moreover, an increased synthesis of ET-1 (Wang et al., 1996) with consecutive activation of the ET A -R and/or ET B -R (Douglas et al., 1995; Tsujino et al., 1995) has been implicated in restenosis following percutaneous transluminal coronary angioplasty (PTCA). Unfortunately, most of the endothelin receptor antagonists developed thus far seem to encounter toxicological problems when administered to patients over a prolonged period of time. Therefore, elucidating the transcriptional mechanisms involved in endothelin receptor expression may provide a novel approach to suppress the activity of the endothelin system in the aforementioned cardiovascular complications.
Recent progress in molecular biology has spurred the development of new techniques for specifically inhibiting expression of a target gene. Antisense oligodeoxynucleotides (ODN) are single-stranded synthetic DNA molecules that after internalization, a process which is dependent on the sequence of the ODN (Etore et al., 1998) , hybridize with the expressed mRNA of the target gene, hence preventing its translation (Phillips and Gyurko, 1997) . A related powerful tool to prevent transcription of a target gene is the transfection of cells with double-stranded phosphorothioate-stabilized decoy ODN (Morishita et al., 1998) . After entering the cells, these decoy ODN scavenge endogenous transcription factors, thereby preventing them from binding to the promoter of the target gene and effectively suppressing mRNA synthesis. In addition, decoy ODN can be used to directly study the transcriptional control of a gene of interest in cultured cells as well as in native cells in situ. By employing this technique, for example, cis-elements regulating basal transcription of the ET A -R gene in a rat SMC line have recently been identified (Yamashita et al., 1998) .
In the present study we have used the decoy ODN technique in combination with electrophoretic mobility shift analysis (EMSA) to identify transcription factors involved in ET B -R expression in cultured SMC from the aorta and mesenteric vascular bed of the rat.
Materials and Methods
Cell Culture. SMC were isolated from the aorta of male Wistar rats (250-300 g body weight) by using the explant technique essentially as described (Krzesz et al., 1999) . They were seeded into collagen type 1 or gelatin-coated 60-mm Petri dishes for EMSA and Western blot analysis or into 6-well plates for RT-PCR analysis (2 mg/ml collagen or gelatin in 0.1 M HCl for 30 min at ambient temperature). All incubations were performed in Waymouth medium containing 10% fetal bovine serum (FBS; Life Technologies, Karlsruhe, Germany) with SMC grown to at least 80% confluence. Incubations were terminated by washing the cells with Hanks' balanced salt solution (HBSS) followed by mRNA or protein extraction. Cell viability was assessed by light microscopy as well as by a colorimetric assay with the tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT; Denizot and Lang, 1986) .
SMC from the mesenteric vascular bed of the rat were isolated after enzymic digestion for 1 h at 37°C with 10 mg/ml collagenase, 20 mg/ml BSA, 5 mg/ml elastase, 10 mg/ml trypsin inhibitor, and 10 mg/ml DNase followed by filtration of the cell suspension through a nylon membrane. The isolated mesenteric SMC were cultured in the same way as the aortic SMC described above.
Cells used for the experiments described below were derived from passages 2 to 4 of individual preparations (i.e., aorta and mesenteric vascular bed from different rats). The homogeneity of the cultured SMC was assessed by positive immunostaining for smooth muscle ␣-actin as described (Krzesz et al., 1999) .
RT-PCR Analysis. Total RNA was isolated from the SMC by solid-phase extraction with the RNeasy kit from Qiagen (Hilden, Germany). Reverse transcription and polymerase chain reaction were performed essentially as described previously (Krzesz et al., 1999) . Amplification of elongation factor 2 (EF-2) cDNA served as an internal standard. The following primers with the respective GenBank accession number, position of the PCR product in the coding sequence, and predicted size were used for amplification: ET A -R (M60786, position 713-1258, 546 bp) 5Ј-TTCGTCATGGTACCCT-TCGA-3Ј (sense) and 5Ј-GATACTCGTTCCATTCATGG-3Ј (antisense); ET B -R (X57764, position 1216-1689, 474 bp) 5Ј-TTCACCTCAGCAG-GATTCTG-3Ј (sense) and 5Ј-AGGTGTGGAAAGTTAGAACG-3Ј (antisense); vascular cell adhesion molecule-1 (VCAM-1; M84488, position 829-1933, 1105 bp) 5Ј-TGGAGCAAGAAATTAGATAATGG-3Ј (sense) and 5Ј-CACATGTACAGGAGATGATGA-3Ј (antisense); inducible nitric-oxide synthase (iNOS; D44591, position 22-848, 827 bp) 5Ј-ATGGCTTGCCCCTGGAAGTTTCTC-3Ј (sense) and 5Ј-CCTCTGATG-GTGCCATCGGGCATCTG-3Ј (antisense); EF-2 (Z11692, position 1990-2207, 218 bp) 5Ј-GACATCACCAAGGGT-GTGCAG-3Ј (sense) and 5Ј-GCGGTCAGCACACTGGCATA-3Ј (antisense).
To ensure that the PCR amplification was indeed semiquantitative, i.e., in the linear phase of the exponential amplification curve, each PCR protocol was established for different numbers of cycles and amounts of cDNA. Furthermore, for each newly synthesized cDNA, the abundance of EF-2 cDNA was measured first, calculated, and used as a reference point to adjust the amount of cDNA from each sample for PCR amplification.
Western Blot Analysis. Analysis of ET B -R protein expression in the cultured smooth muscle cells was performed as described (Hecker et al., 1994) with the modification that the whole cell homogenate was additionally treated for 15 min with 0.5% (w/v) CHAPS at 0-4°C to enrich the membrane-bound ET B -R protein in the 10,000g supernatant. Protein extracts (10-50 g of protein per lane) were separated by denaturing 10% polyacrylamide gel electrophoresis in the presence of SDS according to standard protocols and then transferred to a BioTrace polyvinylidene fluoride transfer membrane (Pall Corporation, Roßdorf, Germany). Transferred proteins were probed by an ET B -R-specific antiserum (␣-CLK23; Cramer et al., 1997 ) at a dilution of 1:2500. Visualization of the protein bands was achieved by using a secondary anti-rabbit antibody conjugated to horseradish peroxidase (1:3000 dilution; Sigma-Aldrich, St. Louis, MO), and the chemiluminescence detection method (SuperSignal chemiluminescent substrate; Pierce Chemical, Rockford, IL) was used followed by exposure to an autoradiography film Hyperfilm MP (Amersham Pharmacia Biotech, Buckinghamshire, England). Thereafter, the loading and transfer of equal amounts of protein in each line was verified by staining of the protein bands on the transfer membrane with India Ink followed by densitometry.
EMSA. Nuclear extracts from the cultured SMC were prepared as described previously (Krzesz et al., 1999) . The double-stranded gel shift oligonucleotides (Santa Cruz Biotechnology, Heidelberg, Germany) for activator protein-1 (AP-1, 5Ј-CGCTTGATGACTCAGCCGGAA-3Ј); CCAAT/enhancer-binding protein (C/EBP, 5Ј-TGCAGATTGCGC-AATCTGCA-3Ј); nuclear factor B (NF-B, 5Ј-AGTTGAGGGGACTT-TCCCAGGC-3Ј); and GATA-2 (5Ј-CACTTGATAACAGAAAGTGATA-ACTCT-3Ј) were end-labeled with [␥-32 P]ATP by using the 5Ј-endlabeling kit from Amersham Pharmacia Biotech (Freiburg, Germany). Typically the binding mixture contained 3 to 10 g of nuclear extract, 10,000 to 20,000 cpm of the 32 P-labeled oligonucleotide probe (0.5 ng), 1 g of poly[d(I-C)], and 1.33 mM D,L-dithiothreitol in a total volume of 15 l of binding buffer. After 30 min at room temperature, the DNAprotein complexes were resolved by nondenaturing 4% polyacrylamide gel electrophoresis. The gel was dried and the complexes visualized by autoradiography. The specificity of the binding reaction was monitored by performing the assay in parallel with the same samples in the presence of a 100-to 1000-fold excess of the nonlabeled oligonucleotide. For supershift analyses, 1.0 to 2.0 l of the appropriate gel supershift antibody (200 g/0.1 ml, Santa Cruz Biotechnology) per 6.0 to 7.0 l of nuclear extract (3-10 g of protein) were preincubated overnight at 4°C or at room temperature for 60 min before the EMSA was performed.
Reporter Gene Analysis. The pAP-1(PMA)-TA-Luc vector (CLONTECH, Heidelberg, Germany) was used to show the activation of the transcription factor AP-1 by PDTC. The pCMV TK lucϩ expression vectors (GenBank accession no. AF027129) containing the Ϫ168-bp fragment of the rat preproendothelin-1 promoter as well as the control vectors with and without the CMV promoter were prepared as described (Paul et al., 1995) . Cotransfections for normalization of transfection efficacy were performed with the SV40/␤-galactosidase expression vector pUC19 (GenBank accession no. M77789). For transfection, 50% confluent rat SMC were incubated with 1.5 g of plasmid DNA and 18 l of Effectene (Qiagen, Hilden, Germany) for 6 h; thereafter the medium was replaced and the cells cultured until they attained 80% confluence (usually after 18-24 h). They were then incubated with 10 to 100 M PDTC or 0.1 M phorbol 12-myristate 13-acetate (PMA) for 6 h. Luciferase and ␤-galactosidase activities in the cell lysates were determined by using corresponding chemiluminescence and photometric assay kits (Promega, Mannheim, Germany).
Decoy Oligodeoxynucleotide Technique. Double-stranded ODN were prepared from complementary single-stranded phosphorothioate-bonded ODN obtained from Eurogentec (Köln, Germany) by melting at 95°C for 5 min followed by a cool-down phase of 3 to 4 h at ambient temperature. The efficiency of the hybridization reaction was verified with 2.5% agarose gel electrophoresis and usually found to exceed 85%. The sequences of the single-stranded ODN were as follows (underlined letters denote phosphorothioate-bonded bases): AP-1, CGCTTGATGACTCAGCCGGAA; AP-1mut, CGCTTGATTACTTAGC-CGGAA; C/EBP, TGCAGATTGCGCAATCTGCA; C/EBPmut, TGCA-GAGACTAGTCTCTGCA; NF-B, AGTTGAGGGGACTTTCCCAGGC; GATA-2, CACTTGATAACA-GAAAGTGATAACTCT. On the basis of previous EMSA and RT-PCR analyses, the maximally effective concentration and the optimal preincubation time for all decoy ODN in the cultured SMC were determined to be 10 M and 4 h. Transfection of the decoy ODN was achieved without using any cationic lipid or liposomal complex. Thereafter the decoy ODN-containing medium was removed, cells were washed twice with medium, and then incubated in fresh medium containing the various test compounds for the indicated periods of time. Decoy ODN treatment also preceded transient transfection of the cultured SMC with the aforementioned reporter gene constructs. Staining of Nuclear DNA with H 33342. After termination of the incubation period, SMC were washed twice with HBSS and then incubated with fixation buffer (5% formaldehyde in 145 mM NaCl, 10 mM Hepes ϫ KOH, pH 7.5) for 20 min at room temperature. After this period the fluorescent bisbenzimide dye H 33342 (Calbiochem, Bad Soden, Germany) was added at a final concentration of 10 g/ml and the cells were incubated for a second period of 20 min. Thereafter, the buffer was replaced by 50% glycerol in HBSS, and the fixed cells were examined by using a video imaging system (Visitron, Mü nchen, Germany). Nuclear staining intensity and morphology were evaluated optically and documented by using the MetaMorph V3.0 software package (Universal Imaging Co., West Chester, PA).
Data Analysis. Unless indicated otherwise, results are expressed as mean Ϯ S.E.M. of n observations. Student's unpaired t test was used to determine differences between the means with a P value Ͻ0.05 considered to be statistically significant.
Results
ET B -R Expression. In aortic and mesenteric SMC grown on either plain plastic, fibronectin, gelatin, or collagen, basal ET B -R mRNA levels were either not (Fig. 1, a and b) or only hardly detectable (Fig. 1c) . Tumor necrosis factor ␣ (TNF␣; 1000 U/ml), interleukin-1␤ (IL-1␤; 60 U/ml) or interferon-␥ (IFN␥; 200 U/ml) alone or in combination (Fig. 1a) failed to induce ET B -R expression. This was also the case when the aortic SMC had been isolated enzymatically instead of using the explant technique (not shown). The cytokines, on the other hand, especially when combined, significantly enhanced the expression of other gene products, such as iNOS and VCAM-1 mRNA (Fig. 2) , in the cultured SMC. Moreover, in endothelium-intact or denuded ring segments of the rat aorta (i.e., native endothelial and smooth muscle cells), there was also no increase in ET B -R mRNA abundance following 6 h of exposure to the cytokines (not shown).
Unexpectedly, PDTC, an inhibitor of NF-B activation Schreck et al., 1992) that was used to modulate cytokinestimulated iNOS gene expression, elicited a pronounced increase in ET B -R mRNA both in aortic and mesenteric SMC in a time-and concentration-dependent manner (maximum at 100 M and 6 h; Fig. 1b) . The cytokine-stimulated increase in iNOS and VCAM-1 mRNA abundance, on the other hand, was significantly inhibited in the presence of 100 M PDTC (by 96 and 70%, respectively), whereas basal ET A -R mRNA levels remained unchanged in PDTC-treated SMC (118 Ϯ 11% of control, n ϭ 4). Coincubation with actinomycin D (1 M) abolished the PDTC-induced increase in ET B -R mRNA (Fig. 1c) . Moreover, PDTC-induced ET B -R expression was reduced by approximately 30% in the presence of TNF␣ plus IL-1␤ (1 h of preincubation with PDTC before addition of the cytokines; Fig. 3) . No difference could be detected in the ability of PDTC to stimulate ET B -R expression in either type of SMC or in the native SMC. Moreover, the protein kinase C inhibitor, RO 31-8220 (0.1 M), had no effect on PDTCstimulated ET B -R expression (not shown). Transcription Factor Activation. EMSA of nuclear extracts prepared from the cultured SMC after 90 min of exposure to 100 M PDTC alone revealed a significant increase in the amount of AP-1, two members of the C/EBP family of transcription factors, C/EBP␤ and -␦, and of GATA-2 in the nucleus (Fig. 4) . Addition of PDTC to the SMC 1 h before IL-1␤ and TNF␣ only slightly attenuated the cytokine-stimulated translocation of NF-B to the nucleus, whereas the activity of both AP-1 and C/EBP was enhanced in response to this agent. Interestingly, PDTC at this concentration almost completely inhibited NF-B activation in the presence of TNF␣ plus IFN␥ (Krzesz et al., 1999) . Cytokine-stimulated GATA-2 transfer to the nucleus, on the other hand, was modestly attenuated in the presence of PDTC (Fig. 4) . Supershift analysis (Fig. 5) revealed two GATA-2-specific DNAprotein complexes in the nuclear extracts of the SMC. Further supershift analyses confirmed that PDTC enhanced mostly C/EBP␤ (Fig. 5) , and that the two NF-B-specific complexes consisted of the p65/50 heterodimer and the p50/50 homodimer (Krzesz et al., 1999) .
Effects of the Decoy ODN. Pretreatment of the cultured SMC with the AP-1, C/EBP, or GATA-2-specific decoy ODN individually reduced PDTC-induced ET B -R expression to 51, 47, and 66% of the stimulated control, respectively (Fig. 3) .
The NF-B-specific decoy ODN (Fig. 3b) and the AP-1 and C/EBP mutant decoy ODN, which were used as controls, on the other hand, had no effect on PDTC-induced ET B -R expression (Fig. 1c) . According to EMSA, the decoy ODNs were highly specific for their target transcription factor. Thus, abundance of the target transcription factor was significantly reduced in nuclear extracts prepared from cells treated with the corresponding decoy ODN, whereas translocation of other transcription factors to the nucleus was not affected (Fig. 6) . Moreover, pretreatment with the C/EBP consensus decoy ODN significantly reduced cytokine-stimulated iNOS gene expression, which is thought to be C/EBP-dependent (Eberhardt et al., 1998), in the aortic SMC; however, VCAM-1 gene expression, which is thought to be predominantly NF-Bdependent (Libby et al., 1995) , remained largely unaffected (Fig. 2) .
Further proof for the specificity of the decoy ODN approach was obtained in experiments in which the cultured SMC were transiently transfected with a truncated (168 bp) rat preproendothelin-1 promoter construct containing a single, but functionally crucial (Lauth et al., 2000b) , AP-1 binding site. The AP-1 consensus decoy ODN, but not the corresponding mutant decoy ODN, markedly reduced both basal and phorbol ester or PDTC-stimulated luciferase activity in these cells (Fig. 7) . These effects of the AP-1 decoy ODN were more 3 . a, effect of TNF/IL and 10 M each of the AP-1 and C/EBP consensus decoy ODN (4-h preincubation) on 100 M PDTC-stimulated ET B -R expression in rat mesenteric cultured SMC incubated for 6 h. The figure depicts a typical RT-PCR analysis with the relative intensities (%), as judged by densitometry, indicated at the top. b, statistical summary of the effects of the consensus AP-1, C/EBP, and GATA-2-specific decoy ODN on PDTC-stimulated ET B -R expression (calculated as percentage of the stimulated control) in rat aortic and rat mesenteric cultured SMC (n ϭ 3-7; *P Ͻ .05 versus PDTC). apparent in SMC grown in serum-reduced medium (0.5% FBS) as compared with complete medium (10% FBS), suggesting that the reporter gene construct also responded to serum, thus reducing the efficacy of the decoy ODN (not shown). The fact that the mutant decoy ODN also displayed a weak inhibitory effect can be attributed to the relatively high concentration used in these experiments, which, according to subsequent EMSA, renders this slightly modified decoy ODN (as compared with the consensus AP-1 decoy ODN, see Materials and Methods) effective to some extent in scavenging AP-1 (not shown). One additional conclusion that could be drawn from these reporter gene analyses was that PDTC also functionally activated AP-1, and this was verified by its concentration-dependent effects on the expression of a synthetic AP-1 reporter gene transiently transfected into the cultured SMC (Fig. 7a, insert) .
PDTC-Induced Expression of Functional ET B -R Protein. To verify that the PDTC-induced rise in ET B -R mRNA abundance was accompanied by a corresponding increase in receptor protein, Western blot analyses with an ET B -R-specific polyclonal antibody were performed. A protein band of the expected molecular mass (43 kDa, GenBank accession no. 111606) was detected that was up-regulated in PDTC-treated cultured SMC to a variable extent (Fig. 8) . Pretreatment of the cells with the AP-1 consensus decoy ODN, but not with the corresponding mutant decoy ODN, completely abrogated this PDTC-induced increase in ET B -R protein (Fig. 8) . In addition, the presence of functional ET B -R protein was investigated by monitoring ET-1-induced apoptosis of the SMC. The reason for choosing this bioassay method was our recent observation of an enhanced rate of apoptosis in rat aortic cultured SMC in the presence of exogenous ET-1 when ET B -R expression had been up-regulated by exposing the cells to cyclic strain (Cattaruzza et al., 2000) . Previously, ET B -Rmediated apoptosis was verified by flow cytometry, chromatin condensation, DNA ladder formation, and caspase-3 activation; for the present study we analyzed chromatin condensation only.
Neither ET-1 nor BQ 788 alone had a significant effect on SMC apoptosis, whereas PDTC alone caused an approximately 3-fold increase in the number of apoptotic nuclei (Fig.  9) , which, however, did not attain statistical significance. On the other hand, PDTC in concentrations up to 100 M did not exert a cytotoxic effect, as judged by light microscopy and the MTT assay (not shown). In the presence of both PDTC and ET-1, SMC apoptosis increased more than 8-fold, and this pro-apoptotic effect was reduced to the level of PDTC alone in the presence of BQ 788, hence confirming the PDTC-induced increase in ET B -R protein at the functional level. 6 . Example of the specificity of the consensus decoy ODN for C/EBP (Fig. 2) . The abundance of the target transcription factor is significantly reduced in nuclear extracts from consensus but not mutant decoy ODNtreated rat aortic cultured SMC, whereas that of AP-1 is not affected. The figure depicts a typical EMSA. Qualitatively identical results were obtained with a least four further batches of raSMC for each transcription factor. 
Transcriptional Regulation of Endothelin-B Receptor

Discussion
The present findings demonstrate that in contrast to other cytokine-inducible gene products (CD40, iNOS, monocyte chemoattractant protein-1, VCAM-1) ET B -R expression in rat cultured SMC is not up-regulated in the presence of IFN␥, IL-1␤, TNF␣, or their combination. It was shown recently that ET B -R expression in human umbilical vein endothelial cells is significantly increased by TNF␣ when the cells are grown on a fibrin matrix, but down-regulated in cells cultured on plain plastic (Smith et al., 1998) . In the present study with SMC grown on plastic, collagen, fibronectin, or gelatin-coated culture dishes we observed either no effect on basal ET B -R expression or a decrease in PDTC-stimulated ET B -R mRNA expression by this and the two other cytokines.
Moreover, there was no cytokine-inducible ET B -R expression in native endothelial and smooth muscle cells in situ (rat aorta); thus, these cytokines are unlikely to play a role in ET B -R induction in the rat vasculature.
The pyrrolidine derivative of dithiocarbamate, PDTC, is widely used as an inhibitor of NF-B activation in intact cells (Schreck et al., 1992) . It is used as a tool to explore the expression of genes involved in inflammatory processes, and an inhibitory effect of PDTC on gene expression is usually linked exclusively to a prevention of NF-B activation. The present data clearly show that PDTC does not only affect the activity of NF-B but also that of other transcription factors such as AP-1, C/EBP, and GATA-2. Moreover, recent findings from our laboratory also demonstrate that PDTC inhibits the IFN␥-stimulated activation of Stat-1 in rat aortic cultured SMC (Krzesz et al., 1999) . An activation by PDTC of AP-1 leading to an increased expression of other gene products Fig. 7 . Expression of the Ϫ168-bp fragment of the rat preproendothelin-1 promoter construct in rat aortic cultured SMC incubated for 6 h with 100 M PDTC (a) or 0.1 M phorbol ester (PMA) (b) with or without 10 M AP-1 or AP-1mut decoy ODN (dODN denotes the decoy ODN with the mutated core binding site for the AP-1 transcription factor). Qualitatively identical results were obtained with at least two further batches of SMC for each stimulus. Basal luciferase activity in the presence of the AP-1 decoy ODN alone was reduced to 55 Ϯ 14% of control (n ϭ 6). a, the insert shows that PDTC also functionally activates AP-1 verified by its concentration-dependent effects on the expression of a synthetic AP-1 reporter gene transiently transfected into the cultured SMC. Reporter gene, i.e. luciferase activity values were normalized with ␤-galactosidase activities in the cell lysates. such as heme oxygenase-1 (Hartsfield et al., 1998) , manganese superoxide dismutase (Borrello and Demple, 1997) , or intracellular adhesion molecule-1 (Munoz et al., 1996) has also been reported. These effects and that on ET B -R expression, however, may not be related to PDTC itself, but to thiuramdisulfides, the reactive metabolites of these dithiocarbamates (Liu et al., 1998) .
The RNA synthesis inhibitor, actinomycin D, completely abolished PDTC-stimulated ET B -R expression, suggesting that PDTC increased the rate of transcription of the ET B -R gene. To elucidate the transcriptional mechanism by which PDTC up-regulated ET B -R expression in the SMC, four transcription factors (i.e., AP-1, C/EBP, NF-B, and GATA-2) that we considered to be the most promising candidates were investigated. AP-1 was the prime candidate because its activation by PDTC had been described before (see above). In addition, preproET-1 gene expression is regulated by transactivating signals that depend on a cooperative interaction of GATA-2 and AP-1 cis-elements (Kawana et al., 1995) . We reasoned that if expression of the endothelin system, as in the rat carotid artery following PTCA (Wang et al., 1996) , is mediated by the same transcription factors, then GATA-2 should also be a prime candidate. Moreover, from parallel work in our laboratory on deformation-induced expression of the ET B -R in rabbit blood vessels (Lauth et al., 2000a) C/EBP␤ or -␦ had emerged as another important transcription factor. As judged by EMSA and corresponding supershift analyses, PDTC indeed increased the abundance of C/EBP (in particular that of C/EBP␤), AP-1, and GATA-2 in nuclear extracts of the cultured SMC. Both basal-and TNF␣ plus IL-1␤-stimulated NF-B activity, on the other hand, were only moderately affected by PDTC, whereas NF-B activation by TNF␣ plus IFN␥ was strongly reduced (Krzesz et al., 1999) .
Because the sequence of the 5Ј-flanking region of the rat ET B -R gene is as yet unknown, we used consensus decoy ODN to verify that the aforementioned three transcription factors are responsible for the PDTC-induced up-regulation of ET B -R transcription. Phosphorothiorate-modified oligonucleotides are fully resistant to almost all nucleases and have a high biological stability (Monia et al., 1996) . Only after thoroughly testing for their target specificity and optimization of both preincubation time and concentration by EMSA were the decoy ODN used. PDTC-stimulated ET B -R expression in the cultured SMC was indeed significantly decreased, albeit to a different degree after exposure to the consensus decoy ODN against AP-1, C/EBP, or GATA-2, but not when the corresponding mutant decoy ODN were used. The NF-B-specific decoy ODN, on the other hand, had no effect on PDTC-induced ET B -R expression. The specificity of the decoy ODN technique was further substantiated by reporter gene analysis with an AP-1-driven preproendothelin-1 promoter luciferase gene construct transiently transfected into the cultured SMC. These reporter gene analyses also confirmed the PDTC-induced increase in AP-1 activity at the functional level.
On the basis of these findings we conclude that the enhanced transcription of the ET B -R gene in rat cultured SMC in the presence of PDTC is mediated by a PDTC-induced increase in the activity of AP-1, C/EBP␤, and GATA-2. This conclusion is indirectly supported by the putative binding sites for transcription factors that can be identified in the 5Ј-flanking region of the human ET B -R gene (GenBank accession no. D13162), with the reservation that there is indeed a sufficient homology between rat and human ET B -R genes in the promoter region. By using the MatInspector V2.2 software package (Quandt et al., 1995) , we detected a potential binding site for GATA at Ϫ995 bp; three C/EBP sites at Ϫ437, Ϫ348, and Ϫ59 bp; and four AP-1 sites at Ϫ706, Ϫ685, Ϫ369, and Ϫ201 bp. The 5Ј-flanking region of the human ET B -R gene does not seem to contain a classical TATA box or binding sites for NF-B when scanned with the appropriate stringency. The IL-1␤/TNF␣-mediated modest decrease in PDTC-stimulated ET B -R expression, which could be explained by the observed decrease in GATA-2 activity, also argues in favor of an involvement of this transcription factor in ET B -R gene expression.
Exposure of the cultured SMC to PDTC also resulted in an increase in functional ET B -R protein, as verified by the BQ 788-sensitive, ET-1-induced increase in apoptosis. Such a pro-apoptotic effect can also be observed in rat aortic cultured SMC exposed to cyclic strain that is based on an activation of the ET B -R but not the ET A -R (Cattaruzza et al., 2000) , which predominates in these cells under static conditions. One functional consequence of this ET B -R-mediated apoptosis, which can also be observed in native arterial but not venous SMC in situ (Lauth et al., 2000a) , may be the remodeling of the vessel wall in response to a pressure overload such as in restenosis following PTCA (Bennett, 1999) or arterial hypertension. Knowing the transcription factors that mediate this pressure-induced increase in ET B -R expression in the SMC may help to devise new strategies by which this possibly deleterious adaptive response can be prevented.
In summary, the present findings demonstrate that in cultured SMC of the aorta and mesenteric vascular bed of the rat, ET B -R gene expression is up-regulated by PDTC. This stimulation of ET B -R gene expression appears to be mediated by the simultaneous activation of AP-1, C/EBP␤, and GATA-2. Although it is not clear how PDTC up-regulates transcription factor activity, presumably by influencing the activity of certain protein kinases and/or phosphatases, this effect may not be caused by PDTC itself, but by the corresponding thiuramdisulfide metabolite. Regardless of the precise mechanism of action of PDTC, this agent may be used as a surrogate stimulus for the effects of cyclic strain on gene expression in cultured SMC that also seems to be associated with activation of a similar set of transcription factors. The highly significant suppression of PDTC-stimulated ET B -R expression by the corresponding decoy ODN finally verifies the feasibility of the decoy ODN strategy for studying the transcriptional regulation of disease-related genes in vitro and may contribute to the development of new therapeutic concepts on this basis.
